SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.April 3, 2015 1:04 p.m. Share
Alastin Skincare Inc., a specialty skin care company in Carlsbad, announced the appointment of Diane Goostree as its new president and CEO.
Molecular diagnostic firm Biocept announced Monday that it has signed two new agreements with preferred provider organization networks — Fortified Provider Network and Three Rivers Provider Network.
The California Life Sciences Association announced Monday that Perry Nisen, CEO of Sanford Burnham Prebys Medical Discovery Institute, will join its board of directors.
AnaptysBio Inc., a biotech developing antibody products for inflammation and cancer, announced the appointment of James A. Schoeneck to its board of directors.
San Diego-based Otonomy Inc., a company that makes treatments for the middle and inner ear, is enrolling the first patients in a Phase 3 clinical trial of OTO-104 for Ménière’s disease, an inner ear disorder characterized by severe dizziness, vertigo, and gradual hearing loss.
San Diego’s Gary and Mary West Health Institute will donate its technical and clinical assets of its autism research program to Northeastern University’s Bouvé College of Health Sciences in order to develop more effective interventions for the disorder.
Sharp Chula Vista Medical Center is building a $239 million hospital to keep up with demand in South County.
San Diego-based AmpliPhi Biosciences announced that it has signed a clinical trial agreement with the University of Adelaide to conduct a Phase 1 trial of bacteriophage therapy.
Halozyme Therapeutics, a biotechnology company developing novel oncology and drug-delivery therapies, announced it will expand and open a satellite office in San Francisco.
AMN Healthcare Services Inc. announced that it will acquire global health care staffing firm Lenexa, Kan.-based B.E. Smith for $160 million in cash.
The Council of Community Clinics announced the formation of a new primary care network called Integrated Health Partners, and the appointment of senior health care executive Sabra Matovsky to lead the new venture.
The Salk Institute for Biological Studies has named Nobel Prize-winning scientist Elizabeth Blackburn as president.
Viking Therapeutics, a biopharmaceutical firm, announced Tuesday that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration for a product candidate meant to treat high cholesterol and fatty liver disease.
Illumina Inc. will get a place on the Standard & Poor’s 500 stock index after the close of trading on Wednesday, Nov. 18.
La Jolla-based Ambrx announced the appointment of Dr. Yong-Jiang Hei as chief medical officer, reporting directly to CEO Tiecheng "Alex" Qiao.